Press Releases

 

All Releases | Reset Search
Acquisitions | Business/Product | Corporate | Financial

2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007
DateTitle 
12/17/13Hospira to Present at the J.P. Morgan 32nd Annual Healthcare Conference Jan. 15, 2014Printer Friendly Version
11/26/13Hospira to Host 2013 Investor DayPrinter Friendly Version
11/06/13Hospira Reports Third-Quarter 2013 ResultsPrinter Friendly Version
10/31/13Hospira Shares Results From Two Open-label Extension Studies for Biosimilar Infliximab in Patients With Rheumatoid Arthritis or Ankylosing SpondylitisPrinter Friendly Version
10/23/13Hospira Unveils New Quality Laboratory and Investments at Rocky Mount, N.C., PlantPrinter Friendly Version
10/23/13Hospira Launches Q Core Sapphire Infusion System in the United StatesPrinter Friendly Version
10/22/13Biosimilars Need Same Names as Original Biologics, Hospira Says at World Health Organization (WHO) MeetingPrinter Friendly Version
10/07/13Hospira to Host Conference Call for Third-Quarter 2013 ResultsPrinter Friendly Version
09/10/13Hospira’s Inflectra (infliximab) the first biosimilar monoclonal antibody to be approved in EuropePrinter Friendly Version
08/13/13Hospira to Present at the Morgan Stanley Global Healthcare ConferencePrinter Friendly Version
07/31/13Hospira Reports Second-Quarter 2013 ResultsPrinter Friendly Version
06/28/13Hospira to Host Conference Call for Second-Quarter 2013 ResultsPrinter Friendly Version
06/28/13Hospira's Inflectra™ (infliximab) the first biosimilar monoclonal antibody to receive positive opinion from EMA's CHMP for rheumatoid arthritis, inflammatory bowel disease and plaque psoriasisPrinter Friendly Version
06/03/13Hospira Data on European Biosimilar Epoetin, Retacrit, Affirm Treatment Response, Tolerability in Management of Anemia Secondary to ChemotherapyPrinter Friendly Version
05/14/13Hospira Reappoints Dr. Sumant Ramachandra Chief Scientific OfficerPrinter Friendly Version
05/08/13Hospira Convenes Its 2013 Annual Meeting of ShareholdersPrinter Friendly Version
05/01/13Hospira Reports First-Quarter 2013 ResultsPrinter Friendly Version
05/01/13Hospira Unveils Global Device StrategyPrinter Friendly Version
04/24/13Hospira Marks Five Years of Biosimilars Success at 2013 BIO International ConventionPrinter Friendly Version
04/17/13Hospira to Present at Upcoming Investor ConferencesPrinter Friendly Version
04/15/13Hospira Names Matthew R. Stober Senior Vice President of OperationsPrinter Friendly Version
04/02/13Hospira to Host Conference Call for First-Quarter 2013 ResultsPrinter Friendly Version
03/18/13Hospira Obtains Six Months U.S. Pediatric Exclusivity for Precedex™ (dexmedetomidine HCl) InjectionPrinter Friendly Version
03/18/13Hospira Statement on Rocky Mount Plant InspectionPrinter Friendly Version
03/01/13Hospira Announces Executive ChangesPrinter Friendly Version
02/13/13Hospira Reports Fourth-Quarter and Full-Year 2012 ResultsPrinter Friendly Version
02/05/13Hospira to Present at Upcoming Investor ConferencesPrinter Friendly Version
01/23/13Hospira's TheraDoc™ Infection Control Assistant Ranked #1 in Its Category in the Latest "Best in KLAS" ReportPrinter Friendly Version
01/22/13Hospira and Q Core Medical Sign International Distribution Agreement for Sapphire Infusion SystemPrinter Friendly Version